$LRSV ~~>> About LinkResPet and Link Reservations Inc.
LinkResPet, a subsidiary of Link Reservations Inc. (OTC: LRSV), is CBD Petcare provider dedicated to improving the health and life conditions of pets worldwide. Developing and marketing hemp-based CBD products for cats, dogs and horses, Link Reservations Inc. is currently present in Europe and in the US. A pioneer in the area, LinkResPet products can be found online on: www.linkrespet.com
LinkResPet’s CBD wellness products for dogs, cats and horses are designed to aid in treating common animal health problems such as arthritis and anxiety.
LinkResPet CEO, Rene Lauritsen commented, “It was an honour and a
LinkResPet (OTC: LRSV) enters into Agreement with American Premium Water Corp (OTC: HIPH) to develop first CBD beverage designed for pets
announces that they have signed a letter of intent with American Premium Water (OTC: HIPH) to create a new CBD beverage aimed for pets. The Joint Venture (JV) will plan to launch a new LinkResPet product beverage “powered by” LALPINA CBD by the end of the year.
52WK HIGH .2199
Authorized Shares 250,000,000 05/10/2019
Outstanding Shares 220,095,511 05/10/2019
Market Cap 7,483,247 05/10/2019
80% insiders holding
FLOAT - 30 mil
O/S “HUGE REDUCTION” expected soon! (see tweet attached)
@res_pet
$LRSV announcement: As part of our ongoing efforts to increase shareholder value, our Board of Directors is planning to authorize a reduction in our shares outstanding. A large quantity of common stock will be returned to the treasury for cancellation & a news release will follow 11:39 AM · Mar 21, 2019
https://twitter.com/res_pet/status/1108754998723252224?s=21
SOS ACTIVE https://www.nvsos.gov/sosentitysearch/CorpDet...&nt7=0
recent news releases https://www.otcmarkets.com/stock/LRSV/news
May 09, 2019 We have a number of targets and lots of ambition for this year, including new product launches, partnerships and market expansion, so I look forward to keeping our investors up to date through press releases as we reach each milestone”
CEO Rene Lauritsen
Background*
Mr. Rene Lauritsen has been Chief Operating Officer of Alterola Biotech Inc. since June 21, 2018 and served as the Chief Executive Officer, President, Chief Financial Officer, Principal Executive Officer, Principal Financial Officer, Secretary and Director since February 13, 2012 until April 10, 2017. Mr. Lauritsen area of expertise is working in the information technology field and he has spent this time focusing on helping early and mid-stage companies meet their objectives. He has spent 15 years owning, running and working as an independent business consultant at Capital Nordic Limited. Mr. Lauritsen holds degrees in business administration from Aarhus Business School and IT-administration from Niels Brock Copenhagen Business School. Stock price: ALTA (OTCMKTS) $1.00 https://www.alterolabiotech.com/default.html
LinkResPet, a subsidiary of Link Reservations Inc. (OTC: LRSV), is CBD Petcare provider dedicated to improving the health and life conditions of pets worldwide. Developing and marketing hemp-based CBD products for cats, dogs and horses, Link Reservations Inc. is currently present in Europe and in the US. A pioneer in the area, LinkResPet products can be found online on: www.linkrespet.com
LinkResPet’s CBD wellness products for dogs, cats and horses are designed to aid in treating common animal health problems such as arthritis and anxiety.
LinkResPet CEO, Rene Lauritsen commented, “It was an honour and a
LinkResPet (OTC: LRSV) enters into Agreement with American Premium Water Corp (OTC: HIPH) to develop first CBD beverage designed for pets
announces that they have signed a letter of intent with American Premium Water (OTC: HIPH) to create a new CBD beverage aimed for pets. The Joint Venture (JV) will plan to launch a new LinkResPet product beverage “powered by” LALPINA CBD by the end of the year.
52WK HIGH .2199
Authorized Shares 250,000,000 05/10/2019
Outstanding Shares 220,095,511 05/10/2019
Market Cap 7,483,247 05/10/2019
80% insiders holding
FLOAT - 30 mil
O/S “HUGE REDUCTION” expected soon! (see tweet attached)
@res_pet
$LRSV announcement: As part of our ongoing efforts to increase shareholder value, our Board of Directors is planning to authorize a reduction in our shares outstanding. A large quantity of common stock will be returned to the treasury for cancellation & a news release will follow 11:39 AM · Mar 21, 2019
https://twitter.com/res_pet/status/1108754998723252224?s=21
SOS ACTIVE https://www.nvsos.gov/sosentitysearch/CorpDet...&nt7=0
recent news releases https://www.otcmarkets.com/stock/LRSV/news
May 09, 2019 We have a number of targets and lots of ambition for this year, including new product launches, partnerships and market expansion, so I look forward to keeping our investors up to date through press releases as we reach each milestone”
CEO Rene Lauritsen
Background*
Mr. Rene Lauritsen has been Chief Operating Officer of Alterola Biotech Inc. since June 21, 2018 and served as the Chief Executive Officer, President, Chief Financial Officer, Principal Executive Officer, Principal Financial Officer, Secretary and Director since February 13, 2012 until April 10, 2017. Mr. Lauritsen area of expertise is working in the information technology field and he has spent this time focusing on helping early and mid-stage companies meet their objectives. He has spent 15 years owning, running and working as an independent business consultant at Capital Nordic Limited. Mr. Lauritsen holds degrees in business administration from Aarhus Business School and IT-administration from Niels Brock Copenhagen Business School. Stock price: ALTA (OTCMKTS) $1.00 https://www.alterolabiotech.com/default.html
